Wijerathna, H.M.S.M.; Shanaka, K.A.S.N.; Raguvaran, S.S.; Jayamali, B.P.M.V.; Kim, S.-H.; Kim, M.-J.; Jung, S.; Lee, J.
CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening. Int. J. Mol. Sci. 2024, 25, 10819.
https://doi.org/10.3390/ijms251910819
AMA Style
Wijerathna HMSM, Shanaka KASN, Raguvaran SS, Jayamali BPMV, Kim S-H, Kim M-J, Jung S, Lee J.
CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening. International Journal of Molecular Sciences. 2024; 25(19):10819.
https://doi.org/10.3390/ijms251910819
Chicago/Turabian Style
Wijerathna, Hitihami M. S. M., Kateepe A. S. N. Shanaka, Sarithaa S. Raguvaran, Bulumulle P. M. V. Jayamali, Seok-Hyung Kim, Myoung-Jin Kim, Sumi Jung, and Jehee Lee.
2024. "CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening" International Journal of Molecular Sciences 25, no. 19: 10819.
https://doi.org/10.3390/ijms251910819
APA Style
Wijerathna, H. M. S. M., Shanaka, K. A. S. N., Raguvaran, S. S., Jayamali, B. P. M. V., Kim, S.-H., Kim, M.-J., Jung, S., & Lee, J.
(2024). CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening. International Journal of Molecular Sciences, 25(19), 10819.
https://doi.org/10.3390/ijms251910819